Tracking the Evolution of Management Options in Wet AMD

Sunir Garg, MD


May 09, 2022

Sunir Garg, MD, recalls his first patient with exudative (wet) macular degeneration during residency and the limited therapeutic options that were available to treat this condition at that time, as well as the uncomfortable conversations that he had with patients.

Dr Garg tracks the evolution of therapeutic options in wet AMD from the period in the early 2000s when the only option was laser photocoagulation, to the introduction of anti-VEGF therapy. These current options can not only halt disease progression but also have the potential to restore some vision loss.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.